Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsuru Kawada is active.

Publication


Featured researches published by Mitsuru Kawada.


Tetrahedron Letters | 1999

Enantioselective hydrogenation of β-keto esters catalyzed by P-chiral bis(dialkylphosphino)ethanes-Ru(II)

Toru Yamano; Naohiro Taya; Mitsuru Kawada; Taisheng Huang; Tsuneo Imamoto

Abstract Asymmetric hydrogenation of keto esters using a BisP ∗ RuBr 2 catalyst is reported. High enantioselectivities up to 98% were achieved in the hydrogenation of β-keto esters.


Journal of Bioscience and Bioengineering | 2002

Kinetic Resolution of an Indan Derivative Using Bacillus sp.SUI-12 : Synthesis of a Key Intermediate of the Melatonin Receptor Agonist TAK-375

Naoki Tarui; Yoichi Nagano; Takeshi Sakane; Kiyoharu Matsumoto; Mitsuru Kawada; Osamu Uchikawa; Shigenori Ohkawa; Kazuo Nakahama

The chiral indan derivative (S)-2 (2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl-amine) was synthesized by enzyme-catalyzed asymmetric hydrolysis of the racemic acetamide 1 (N-[2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]acetamide). The reaction was carried out using Bacillus sp. SUI-12 screened for the ability to hydrolyze 1 to give (S)-2 with high enantioselectivity. In a scaled-up experiment, a low reaction rate was observed. However, by changing the culture medium and the reaction conditions, it became possible to run the reaction to 40% conversion on a 10-g or more scale, obtaining (S)-2 at >;99% enantiomeric excess (ee). The (S)-2 obtained was available for the synthesis of the melatonin receptor agonist TAK-375 (N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]propanamide).


Biochimica et Biophysica Acta | 1982

Effects of Q metabolites and related compounds on mitochondrial succinate and NADH oxidase systems

Kayoko Okamoto; Mitsuru Kawada; Masazumi Watanabe; Shigeru Kobayashi; Isuke Imada; Hiroshi Morimoto

The effects of Q metabolites (Q acid-I, Q acid-II) and related compounds (dihydro Q acid-I, dehydro Q acid-II, QS-n, and their esters) on mitochondrial succinate and NADH oxidase systems were investigated. The activity restoring succinate oxidation in acetone-treated beef heart mitochondria was found to decrease with descending order of carbon number (n) of the side chain of the Q metabolites; activity was restored with Q acid-I (n = 7) to one-third as much as that with Q-7 and Q-10, but Q acid-II (n = 5) did not restore any activity. Of the related compounds with a carboxyalkyl group (QS-n), QS-16-QS-18 (n = 16-18) were found to be most active, and their activities were also correlated with n. The relationship between the restoration of activity and the partition coefficient was considered. NADH oxidation in pentane-treated beef heart submitochondrial particles could be restored with esters of low molecular weight quinones to the same extent as with Q-10, but not with the metabolites.


Bioscience, Biotechnology, and Biochemistry | 1996

Purification and Characterization of Ethyl 2-Methyl-3-oxobutanoate Reductase from Klebsiella pheumoniae IFO3319

Hiroyuki Miya; Mitsuru Kawada; Yoshio Sugiyama

An enzyme that catalyzes a reduction of ethyl 2-methyl-3-oxobutanoate (1) to ethyl (2R,3S) 3-hydroxy- 2-methylbutanoate was found in Klebsiella pneumoniae IFO 3319 cells. The enzyme was isolated from the cells and purified 250-fold by ammonium sulfate fractionation, ion exchange chromatography, affinity chromatography, and gel filtration. The purified enzyme was found to be a monomer protein with a molecular weight of approximately 31,000 and an isoelectric point of 6.2. It was NADPH-dependent and had maximum activity at pH 7.0 and 45°C for the reduction and at pH 10.0 and 45°C for oxidation. The Kms at pH 7.0 were 5.6 mM for 1 and 12.5 mM for benzyl 2-methyl-3-oxobutanoate, respectively. Esters of 2-oxocycloalkane carboxylic acids as well as esters of 2-methyl-3-oxobutanoic acid served as substrates, and the corresponding reduced products were obtained with high stereoselectivity.


Journal of Medicinal Chemistry | 2002

Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists

Osamu Uchikawa; Kohji Fukatsu; Ryosuke Tokunoh; Mitsuru Kawada; Kiyoharu Matsumoto; Yumi N. Imai; Shuji Hinuma; Koki Kato; Hisao Nishikawa; Keisuke Hirai; Masaomi Miyamoto; Shigenori Ohkawa


Journal of Medicinal Chemistry | 2002

Novel 5-Substituted 2,4-Thiazolidinedione and 2,4-Oxazolidinedione Derivatives as Insulin Sensitizers with Antidiabetic Activities

Yu Momose; Tsuyoshi Maekawa; Tohru Yamano; Mitsuru Kawada; Hiroyuki Odaka; Hitoshi Ikeda; Takashi Sohda


Chemical & Pharmaceutical Bulletin | 1982

Synthesis of Quinones having Carboxy- and Hydroxy-Alkyl Side Chains, and Their Effects on Rat-Liver Lysosomal Membrane

Kayoko Okamoto; Masazumi Watanabe; Mitsuru Kawada; Giichi Goto; Yasuko Ashida; Katsuaki Oda; Akiko Yajima; Isuke Imada; Hiroshi Morimoto


Journal of Medicinal Chemistry | 2002

Synthesis of a Novel Series of Benzocycloalkene Derivatives as Melatonin Receptor Agonists

Kohji Fukatsu; Osamu Uchikawa; Mitsuru Kawada; Toru Yamano; Masayuki Yamashita; Koki Kato; Keisuke Hirai; Shuji Hinuma; Masaomi Miyamoto; Shigenori Ohkawa


Chemical & Pharmaceutical Bulletin | 1985

Effects of 6-(ω-Substituted Alkyl)-2, 3-dimethoxy-5-methyl-1, 4-benzoquinones and Related Compounds on Mitochondrial Succinate and Reduced Nicotinamide Adenine Dinucleotide Oxidase Systems

Kayoko Okamoto; Mutsuko Matsumoto; Masazumi Watanabe; Mitsuru Kawada; Tetsuji Imamoto; Isuke Imada


Archive | 1995

Oxazolidinedione derivatives, their production and use

Takashi Sohda; Hiroyuki Odaka; Yu Momose; Mitsuru Kawada

Collaboration


Dive into the Mitsuru Kawada's collaboration.

Top Co-Authors

Avatar

Isuke Imada

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masazumi Watanabe

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hirosada Sugihara

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Toru Yamano

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kiyoharu Matsumoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Morimoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Takashi Sohda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yu Momose

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hiroyuki Odaka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masaaki Tsurushima

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge